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Abstract – Synthetic studies on palmarumycin C6 with a naphthyl acetal at the 
C-3 position in 4,7-dihydroxy-1-indanone as a lower homologue of 
spirobisnaphthalenes are described herein. We investigated three approaches: 1) 
Nazarov cyclization of benzoylketene acetal, 2) intramolecular Friedel-Crafts 
acylation of naphtho[1,8-de]-1,3-dioxin-2-aryl-2-acetic acid chloride, and 3) 
double oxa-Michael addition of 1,8-dihydroxynaphthalene to 3-bromo-1-indenone. 
The last approach successfully afforded the natural product after the removal of 
acetates that serve as protecting groups for phenolic hydroxyls under acidic 
conditions. 
INTRODUCTION 
Spirobisnaphthalenes are fungal secondary metabolites that have unique, highly oxidized structures and 
diverse biological activities.1 Their structural complexity and important biological activities have 
prompted significant research into their synthesis. Most of this research has focused on 
C10-spirobisnaphthalenes with a naphthyl acetal on a six-membered ring. However, some members of the 
spirobisnaphthalene family have a 9-carbon skeleton bearing the naphthyl acetal on a five-membered 
ring.2–5 The formation of an acetal from 1,8-dihydroxynaphthalene (DHN) is not trivial because the 
conventional method, which is performed under acidic conditions, also leads to competitive 
autopolymerization of 1,8-dihydroxynaphthalene and can only be applied to the synthesis of the former 
six-membered-ring acetal.6 Thus, if we are to synthesize the latter five-membered-ring acetal 
spirobisnaphthalene analogs, the development of an efficient method for constructing the acetal under 
neutral or basic conditions is required. 
Recently, we reported the synthesis of spiromamakone A benzo analogs based on a double 
oxa-Michael addition of 1,8-dihydroxynaphthalene to 2-(pseudohalo)alkylidene-1,3-cyclopentanedione 
under basic conditions.7 In addition, we also reported an alternative method for constructing the acetal 
 
based on conjugate addition of carbon- or heteroatom-nucleophiles to β-oxoketene naphthyl acetals 
prepared from 3-bromo-2-propyn-1-ones.8 
Herein, we describe three approaches to synthesize palmarumycin C6 (1),
2 which was isolated from 
Coniothyrium sp. and has never been synthesized (Scheme 1). Although no biological activity for this 
compound itself has been reported, the structural motif upon which it is based can be seen in other natural 
products3 as well as biologically active spiromamakone A benzo analogs.7 
 
We investigated three synthetic approaches, as shown in Scheme 1: 1) Nazarov cyclization9 of aryl 
vinyl ketone 3 derived from 1-aryl-3-bromo-2-propyn-1-one 4, 2) intramolecular Friedel-Crafts acylation 
of 5 prepared by arylation of β-oxoketene naphthyl acetal 6 with 7 followed by transformation of the ester 




Scheme 1 Retrosyntheses of palmarumycin C6 (1) 
 
RESULTS AND DISCUSSION 
First, aryl vinyl ketone 3a for the Nazarov cyclization was readily prepared from commercially available 
2,5-dimethoxybenzaldehyde (9) (Scheme 2). Addition of lithium (trimethylsilyl)acetylide to 9 and 
subsequent oxidation with MnO2 afforded TMS-protected ethynyl ketone 10 in good yield. Substitution 
















































silver nitrate,11 which was followed by double oxa-Michael addition of DHN to give acylketene acetal 3a. 
Although a variety of reaction conditions have been explored for the Nazarov cyclization of substituted 
aryl vinyl ketones, including Brønsted acids (PPA12, MsOH13, TfOH14, and TFA15), Lewis acids 
(BF3·OEt2
16, FeCl3
17, TMSOTf18, and AlCl3
19), and UV irradiation,20, 21 none of these conditions 
converted 3a to naphthyl acetal 11a. Steric and electronic factors in the naphthyl acetal moiety destabilize 
the s-trans conformer of 3a and stabilize the pentadienyl cation, respectively, preventing cyclization.22 It 
should be noted that heating 3a in trifluoroacetic acid led to the formation of 12, which results from the 
liberation of DHN from 3a followed by 1,4-addition of DHN to another molecule of 3a and dehydration. 
 
Scheme 2 Attempted synthesis of 11a via Nazarov cyclization of 3a 
 
During screening of the reaction conditions for the Nazarov cyclization of 3a, 1,4-addition of 
toluene (employed as the solvent) to acylketene acetal 3a was observed under AlCl3 catalysis.
23 The 
corresponding ester 68 also underwent arylation with 1,4-dimethoxybenezene to give naphthyl acetal 13 
(Scheme 3). Instead of arylmetal species, electron-rich arenes can be used as nucleophiles for the 
conjugate addition to acylketene acetal 6 under acidic conditions. Hydrolysis of the methyl ester in 13 and 
subsequent treatment with oxalyl chloride yielded acid chloride 5a. Unfortunately, neither AlCl3
24 nor 







10: X = TMS








































Scheme 3 Attempted synthesis of 11a via intramolecular Friedel–Crafts acylation of 5a 
 
Finally, double oxa-Michael addition of DHN to 3-halo- and 3-pseudohalo-1-indenones was attempted 
(Table 1). The starting Michael acceptors 8a–c and 17 were prepared as shown in Scheme 4. Sulfone 8a 
with two methyl ethers was prepared by oxidation of literature-known sulfide 15.26 Preparation of 
3-bromo-1-indenone 8b from its parent indanone 1627 based on a one-pot sequence involving 
radical-mediated dibromination of the benzylic methylene carbon and base-promoted elimination of HBr 
also afforded dibromide 17 and 1-indenone 18.28 Conversely, Michael acceptor 8c, in which two 
hydroxyl groups are protected by acetyl groups instead of methyl groups, was selectively synthesized 
from acetate 1929 by the above one-pot sequence. It is noteworthy that the efficiency of the one-pot 
sequence was strongly influenced by the electron density of the benzene ring. 
 
Unlike the vinylogous acyl sulfone activated by two carbonyl groups that we previously reported,7 
vinylogous acyl sulfone 8a did not undergo an addition-elimination reaction with 2 in the presence of a 
stoichiometric amount of DABCO as base (Table 1, Entry 1). However, the corresponding bromide 8b 
was converted to the naphthyl acetal 11a under the same reaction conditions (Entry 2). 
2,3-Dibromo-1-indenone 17, which was obtained as a side product during the preparation of 8b, also 
participated in the double oxa-Michael addition of 2 to give 2-bromo-1-indanone 20 in good yield (Entry 
3). The α-bromo substituent in 20 was reduced using zinc powder in acetic acid to afford 11a in 93% 
















13: R =  Me (83%)





















successfully transformed into naphthyl acetal 11b without elimination of the acetyl groups (Table 1, 
Entry 4). 
 
Scheme 4 Preparation of Michael acceptors 8a–c and 17 for double oxa-Michael addition of 2 
 
Table 1 Double oxa-Michael addition of 2 to Michael acceptors 8a–c and 17 
 
 
Entry Michael acceptor X Y R Product Yield 
1 8a SO2Ph H Me 11a 0% 
2 8b Br H Me 11a 50% 
3 17 Br Br Me 20 62% 
















8b: Y = H (35%)














1) BBr3, CH2Cl2, 48%
2) Ac2O, Et3N, DMAP














8a–c, 17 (1.2 equiv)
 
Finally, deprotection of the two methyl ethers in 11a was investigated (Scheme 5). Although BBr3 has 
been employed for the removal of methyl groups from a substrate with a naphthyl acetal on tetralone,30 
treatment of 11a with BBr3 resulted in decomposition of the substrate. Interestingly, acid hydrolysis of 
the acetate 11b proceeded well to produce palmarumycin C6 (1) in quantitative yield, whereas basic 




Scheme 5 Total synthesis of palmarumycin C6 (1) 
 
In summary, we have achieved the first total synthesis of palmarumycin C6 (1) through five steps 
from 4,7-dimethoxy-1-indanone (16) using double oxa-Michael addition of DHN to 3-bromo-1-indenone 
in the presence of DABCO. Although the naphthyl acetal is very sensitive to the deprotection conditions, 
acid hydrolysis of the phenolic acetates led to the successful formation of the natural product. Syntheses 
of other spirobisnaphthalene analogs based on the current methodology are underway. 
EXPERIMENTAL 
All commercially available reagents and anhydrous solvents including acetone, dichloromethane, and 
tetrahydrofuran (THF) were purchased and used without further purification otherwise noted. Anhydrous 
acetonitrile (MeCN), N, N-dimethylformamide (DMF), and nitromethane were obtained by distillation 
from calcium hydride. Anhydrous methanol (MeOH) was obtained by distillation from magnesium. All 
reactions were monitored by thin layer chromatography (TLC) performed on 0.25 mm silica gel glass 
plates (60 F254) using UV light and ethanolic p-anisaldehyde-sulfuric acid, aqueous cerium 


































    decomp.
B) 6 M HCl, MeOH
    65 °C, quant.
 
carbonate-sodium hydroxide solutions as visualizing agents. Yields refer to chromatographically and 
spectroscopically homogeneous materials. Melting points were measured on a melting point apparatus 
and were uncorrected. Only the strongest and/or structurally important absorptions of infrared (IR) 
spectra are reported in reciprocal centimeters (cm-1). 1H NMR spectra (400 MHz and 600 MHz) and 
13C{1H}NMR spectra (100 MHz and 151 MHz) were recorded in the indicated solvent. Chemical shifts 
(δ) are reported in delta (δ) units, parts per million (ppm). Chemical shifts for 1H NMR spectra are given 
relative to signals for internal tetramethylsilane (0 ppm) or residual nondeuterated solvents, i.e., 
chloroform (7.26 ppm), methanol (3.30 ppm) and dimethyl sulfoxide (DMSO, 2.49 ppm). Chemical shifts 
for 13C NMR spectra are given relative to the signal for CDCl3 (77.0 ppm), CD3OD (49.0 ppm) and 
DMSO-d6 (39.7 ppm). Multiplicities are reported by the following abbreviations: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet), br (broad). Coupling constants (J) are represented in hertz (Hz). 1H 
and 13C NMR chemical shifts were assigned using a combination of COSY, NOESY, HMQC, and 
HMBC. EI mass spectra and EI high resolution mass spectra were measured on a JEOL JMS-DX303, 
JMS-700 and JMS-T100GC. ESI high resolution mass spectra were measured on a Thermo ScientificTM 
ExactiveTM Plus Orbitrap mass spectrometer. 
 
1-(2,5-Dimethoxyphenyl)-3-(trimethylsilyl)prop-2-yn-1-one (10): To a stirring solution of 
trimethylsilylacetylene (3.3 mL, 24 mmol) in anhydrous THF (20 mL) was added BuLi (8.2 mL, 22 mmol, 
2.69 M in hexane) under argon atmosphere at −78 °C. After being stirred at the same temperature for 30 
min, the resulting solution was treated with a solution of 2,5-dimethoxybenzaldehyde (9) (3.32 g, 20.0 
mmol) in anhydrous THF (20 ml). The mixture was warmed to room temperature and stirred for another 
2.5 h before being treated with saturated aqueous NH4Cl. The aqueous layer was extracted with EtOAc 
twice. The combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo to yield 1-(2,5-dimethoxyphenyl)-3-(trimethylsilyl)prop-2-yn-1-ol, which was used for the next 
reaction without further purification. 
 To a stirring solution of the crude propargyl alcohol in CH2Cl2 was added MnO2 (20 g). After 
being stirred at room temperature for 3 h, the reaction mixture was filtered through a Celite pad, which 
was thoroughly rinsed with CH2Cl2. The filtrate was concentrated in vacuo to yield the title compound 
(5.17 g, 19.7 mmol, 99%) as a yellow oil, which was pure enough for analysis. Rf 0.19 (33% 
EtOAc/hexane). IR ν (neat, cm-1): 2959, 2836, 2151, 1650, 1496, 1464, 1415, 1281, 1228, 1176, 1039, 
849, 762. 1H-NMR (400 MHz, CDCl3): δ 7.52 (d, J = 3.2 Hz, 1H), 7.09 (dd, J = 9.2, 3.2 Hz, 1H), 6.94 (d, 
J = 9.2 Hz, 1H), 3.88 (s, 3H), 3.81 (s, 3H), 0.29 (s, 9H). 13C-NMR (100 MHz, CDCl3): δ 176.5, 155.1, 
 
153.7, 127.2, 122.5, 116.3, 114.7, 103.7, 99.4, 57.0, 56.4, 0.00. HRMS (ESI, [M+H]+): calcd for 
C14H19O3Si, 263.1098; found, 263.1094. 
  
1-(2,5-Dimethoxyphenyl)-2-(naphtho[1,8-de][1,3]dioxin-2-ylidene)ethan-1-one (3a): To a stirring 
solution of TMS-protected ethynyl ketone 10 (528 mg, 2.01 mmol) in anhydrous acetone (7 mL) were 
added AgNO3 (70.4 mg, 0.414 mmol) and N-bromosuccinimide (428 mg, 2.40 mmol) under argon 
atmosphere. After being stirred at room temperature for 3 h, the mixture was treated with another portion 
of N-bromosuccinimide (72.9 mg, 0.410 mmol) and stirred for 1 h. Again, another portion of 
N-bromosuccinimide (37.7 mg, 0.212 mmol) was added to the mixture. The mixture was stirred at the 
same temperature for another 2 h before being filtered through a Celite pad, which was thoroughly rinsed 
with Et2O. The filtrate was washed with 20% aqueous Na2S2O3∙5H2O and H2O, dried over MgSO4, and 
concentrated in vacuo to yield 3-bromo-1-(2,5-dimethoxyphenyl)prop-2-yn-1-one, which was used for the 
next reaction without further purification. 
 To a stirring solution of the crude 3-bromo-1-(2,5-dimethoxyphenyl)prop-2-yn-1-one and 
1,8-dihydroxynaphthalene (313 mg, 1.95 mmol) in anhydrous CH2Cl2 (10 mL) was added 
1,4-diazabicyclo[2.2.2]octane (222 mg, 1.98 mmol) at 0 °C under argon atmosphere. After being stirred at 
room temperature for 4 h, the reaction mixture was diluted with Et2O. The organic layer was washed with 
1 M aqueous HCl, 1 M aqueous NaOH, H2O and brine, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by silica gel chromatography eluting with 10–33% EtOAc/hexane to yield the 
title compound (572 mg, 1.64 mmol, 84 %) as a dark green oil. Rf 0.19 (33% EtOAc/hexane). IR ν (neat, 
cm-1): 3003, 2942, 2834, 1668, 1557, 1494, 1415, 1380, 1273, 1221, 1037, 926, 844, 812, 752. 1H-NMR 
(400 MHz, CDCl3): δ 7.53 (d, J = 8.3 Hz, 2H), 7.45 (dd, J = 8.3, 7.3 Hz, 1H), 7.44 (dd, J = 8.3, 7.3 Hz, 
1H), 7.23 (dd, J = 3.2 Hz, 1H), 7.00–6.96 (m, 3H), 6.91 (d, J = 9.0 Hz, 1H), 6.06 (s, 1H), 3.85 (s, 3H), 
3.81 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ 189.3, 158.2, 153.5, 151.7, 144.3, 143.9, 133.4, 131.6, 
127.9, 127.7, 121.8, 121.6, 118.0, 113.9, 113.0, 110.6, 108.3, 107.6, 89.0, 56.4, 55.7. HRMS (ESI, 
[M+H]+): calcd for C21H17O5, 349.1071; found, 349.1064.  
 
2-(2,5-Dimethoxyphenyl)spiro[benzo[h]chromene-4,2'-naphtho[1,8-de][1,3]dioxin]-10-ol (12): To a 
test tube containing 1-(2,5-dimethoxyphenyl)-2-(naphtho[1,8-de][1,3]dioxin-2-ylidene)- 
ethan-1-one (3a) (20.0 mg, 0.0574 mmol) was added TFA (300 μL) under argon atmosphere. The 
resulting mixture was sealed with a screw cap, stirred at 72 °C for 5 h, cooled to room temperature, and 
then treated with H2O and EtOAc. The aqueous layer was extracted with EtOAc twice. The combined 
organic layers were washed with saturated aqueous NaHCO3, brine, dried over MgSO4, and concentrated 
in vacuo. The residue was purified by preparative TLC eluting with 50% EtOAc/hexane to yield the title 
compound (10.0 mg, 0.0204 mmol, 71% based on dihydroxynaphthalene unit) as a green oil. Rf 0.45 
 
(50% EtOAc/hexane). IR ν (neat, cm-1): 3449, 3056, 3008, 2935, 2835, 1605, 1583, 1497, 1412, 1383, 
1270, 1234, 1087, 1058, 912, 822, 755. 1H-NMR (600 MHz, CDCl3): δ 9.10 (s, 1H), 7.87 (d, J = 8.7 Hz, 
1H), 7.73 (d, J = 8.7 Hz, 1H), 7.54 (d, J = 8.4 Hz, 2H), 7.49 (dd, J = 7.9, 7.9 Hz, 1H), 7.45 (dd, J = 8.4, 
7.6 Hz, 2H), 7.41 (d, J = 7.9 Hz, 1H), 7.05 (d, J = 7.9 Hz, 1H), 6.95 (d, J = 7.6 Hz, 2H), 6.89 (d, J = 8.9 
Hz, 1H), 6.89 (dd, J = 8.9, 2.4 Hz, 1H), 6.81 (d, J = 2.4 Hz, 1H), 5.87 (s, 1H), 3.85 (s, 3H), 3.69 (s, 3H). 
13C-NMR (150 MHz, CDCl3): δ 154.3, 153.5, 151.3, 151.0, 147.91, 147.86, 136.9, 134.3, 129.0, 127.6, 
125.0, 123.4, 122.3, 120.6, 119.3, 116.6, 115.6, 113.5, 113.0, 112.8, 112.6, 112.5, 109.6, 98.5, 94.4, 56.1, 
55.9. LRMS (EI) m/z (relative intensity): 491 [M+1]+ (33), 490 [M]+ (100), 348 (30), 162 (26). HRMS 
(EI, [M]+): calcd for C31H22O6, 490.1416; found, 490.1425. 
 
Methyl 2-(naphtho[1,8-de][1,3]dioxin-2-ylidene)acetate (6): To a stirring solution of 
1,8-dihydroxynaphthalene (2) (1.74 g, 10.9 mmol) and methyl 3-bromopropiolate31 (2.65 g, 16.3 mmol) 
in anhydrous CH2Cl2 (40 mL) was added DABCO (2.66 g, 21.8 mmol) at 0 °C under argon atmosphere. 
After being stirred at room temperature for 3 h, the reaction mixture was treated with 1 M aqueous HCl. 
The aqueous layer was extracted with EtOAc twice. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated in vacuo. The residue was purified by silica gel chromatography 
eluting with 25% EtOAc/hexane to yield the title compound (2.17 g, 8.96 mmol, 82 %) as a white solid. 
Rf 0.34 (20% EtOAc/hexane). Mp 115–118 °C. IR ν (neat, cm
-1): 1721, 1654, 1602, 1419, 1381, 1281, 
1248, 1131, 1089, 815, 799, 753. 1H-NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.3 Hz, 1H), 7.51 (d, J = 
8.3 Hz, 1H), 7.45 (dd, J = 8.3, 7.6 Hz, 1H), 7.42 (dd, J = 8.3, 7.3 Hz, 1H), 7.13 (d, J = 7.3 Hz, 1H), 6.93 
(d, J = 7.6 Hz, 1H), 4.93 (s, 1H), 3.75 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ 166.2, 158.6, 144.4, 144.1, 
133.6, 128.0, 127.8, 121.9, 121.7, 110.6, 108.4, 107.6, 78.1, 51.0. HRMS (ESI, [M+H]+): calcd for 
C14H11O4, 243.0652; found, 243.0653. 
 
Methyl 2-(2-(2,5-dimethoxyphenyl)naphtho[1,8-de][1,3]dioxin-2-yl)acetate (13): To a stirring solution 
of aluminum chloride (66.1 mg, 0.124 mmol) in 1,4-dimethoxybenzene (0.3 mL) was added acylketene 
acetal 6 (30.0 mg, 0.0500 mmol) at 65 °C under argon atmosphere. After being stirred at the same 
temperature for 2 h, the reaction mixture was diluted with Et2O and treated with 1 M aqueous Rochelle 
salt. The aqueous layer was extracted with Et2O twice. The combined organic layers were washed with 
brine, dried over MgSO4, and concentrated in vacuo. The residue was purified by preparative TLC eluting 
with 6% EtOAc/toluene to yield the title compound (21.4 mg, 0.0563 mmol, 56 %) as a yellow solid. Rf 
0.42 (6% EtOAc/toluene). Mp 136–139 °C. IR ν (neat, cm-1): 2952, 2835, 1742, 1607, 1497, 1414, 1381, 
1277, 1227, 1188, 1038, 818, 758. 1H-NMR (600 MHz, CDCl3): δ 7.38–7.32 (m, 4H), 7.35 (d, J = 8.4, 
 
6.7 Hz, 2H), 7.05 (d, J = 3.4 Hz, 1H), 7.01–6.96 (m, 2H), 6.75 (d, J = 9.3 Hz, 1H), 6.66 (dd, J = 3.4, 9.3 
Hz, 1H), 3.86 (s, 3H), 3.65 (s, 3H), 3.55 (s, 3H), 3.51 (s, 2H). 13C-NMR (100 MHz, CDCl3): δ 168.6, 
152.7, 151.5, 147.9, 134.1, 127.2, 127.0, 120.3, 115.25, 115.20, 114.1, 113.5, 108.9, 100.8, 56.5, 55.5, 
51.8, 44.0. LRMS (EI) m/z (relative intensity): 380 [M]+ (78), 307 (30), 221 (100), 206 (27), 189 (25), 
161 (25), 160 (47). HRMS (EI, [M]+): calcd for C16H14O4, 380.1260; found, 380.1253. 
 
2-(2-(2,5-Dimethoxyphenyl)naphtho[1,8-de][1,3]dioxin-2-yl)acetic acid (14): To a stirring solution of 
ester 13 (41.3 mg, 0.109 mmol) in MeOH (0.3 mL) was added 2 M aqueous NaOH (0.6 mL) under argon 
atmosphere. After being stirred at 80 °C for 2 h, the mixture was acidified with 1 M aqueous HCl. The 
aqueous layer was extracted with CHCl3 twice. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated in vacuo to yield the title compound (37.3 mg, 0.102 mmol, 93%) as 
a white solid, which was pure enough for analysis. Rf 0.33 (50% EtOAc/hexane). Mp 173–176 °C. IR ν 
(neat, cm-1): 1710, 1601, 1495, 1411, 1376, 1270, 1220, 1187, 1171, 1036, 815, 768. 1H-NMR (400 MHz, 
CDCl3): δ 9.47 (br-s, 1H), 7.40 (d, J = 8.3 Hz, 2H), 7.36 (dd, J = 8.3, 7.8 Hz, 2H), 7.03 (d, J = 2.9 Hz, 
1H), 7.01 (d, J = 7.8 Hz, 2H), 6.75 (d, J = 9.0 Hz, 1H), 6.67 (dd, J = 9.0, 2.9 Hz, 1H), 3.86 (s, 3H), 3.55 (s, 
3H), 3.54 (s, 2H). 13C-NMR (100 MHz, CDCl3): δ 170.5, 152.5, 151.4, 147.7, 133.9, 127.1, 126.8, 120.2, 
115.1, 114.0, 113.4, 108.8, 100.7, 56.3, 55.3, 43.9 (One signal is missing due to overlap). HRMS (ESI, 
[M+Na]+): calcd for C21H18O6Na, 389.0996; found, 389.0995. 
 
4,7-Dimethoxy-3-(phenylsulfonyl)-1H-inden-1-one (8a): To a stirring solution of 
4,7-dimethoxy-3-(phenylthio)-1H-inden-1-one26 (15) (15.8 mg, 0.0530 mmol) in anhydrous CH2Cl2 (0.5 
mL) was added mCPBA (13.1 mg, 0.0531 mmol, containing ca. 30% H2O) at 0 °C under argon 
atmosphere. After being stirred at the same temperature for 1 h, the mixture was treated with another 
portion of mCPBA (13.1 mg, 0.0531 mmol) and stirred for 30 min. Again, another portion of 
mCPBA(13.0 mg, 0.0530 mmol) was added to the mixture. The mixture was stirred at room temperature 
for another 30 min before being treated with 1 M aqueous Na2S2O3. The aqueous layer was extracted with 
CH2Cl2 twice. The combined organic layers were washed with saturated aqueous NaHCO3 and brine, 
dried over MgSO4, and concentrated in vacuo to yield the title compound (37.3 mg, 0.102 mmol, 93%) as 
a bright red solid, which was pure enough for analysis. Rf 0.28 (50% EtOAc/hexane). Mp 225–228 °C. IR 
ν (neat, cm-1): 1697, 1489, 1279, 1146, 1057, 801, 728, 603. 1H-NMR (400 MHz, CDCl3): δ 7.99 (d, J = 
7.1 Hz, 2H), 7.67 (t, J = 7.5 Hz, 1H), 7.58 (dd, J = 7.5, 7.1 Hz, 2H), 7.01 (d, J = 9.3 Hz, 1H), 6.92 (d, J = 
9.3 Hz, 1H), 6.13 (s, 1H), 3.92 (s, 3H), 3.75 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ 191.4, 158.3, 152.7, 
147.5, 138.8, 133.9, 130.2, 129.0, 128.3, 126.2, 123.2, 118.0, 116.8, 56.6, 56.4. LRMS (EI) m/z (relative 
 
intensity): 331 [M+1]+ (20), 330 [M]+ (100), 189 (36), 175 (15), 161 (27), 159 (23), 131 (15), 125 (21). 
HRMS (EI, [M]+): calcd for C17H14O5S, 330.0562; found, 330.0528.  
 
Bromination of 4,7-dimethoxy-2,3-dihydro-1H-inden-1-one (16): To a stirring solution of 
4,7-dimethoxy-2,3-dihydro-1H-inden-1-one (16) (22.7 mg, 0.118 mmol) in CCl4 (3 mL) were added 
N-bromosuccinimide (44.1 mg, 0.248 mmol) and 2,2'-azobis(isobutyronitrile) (1.9 mg, 0.012 mmol) 
under argon atmosphere. The resulting solution was refluxed for 5 h and then cooled to room temperature. 
Triethylamine (50 μL, 0.361 mmol) was added to the solution and the resulting mixture was stirred at 
room temperature. After being stirred for another 11 h, the mixture was treated with 1 M aqueous 
Na2S2O3. The aqueous layer was extracted with EtOAc twice. The combined organic layers were washed 
with brine, dried over MgSO4, and concentrated in vacuo. The residue was purified by preparative TLC 
eluting with 40% EtOAc/hexane to yield 3-bromo-4,7-dimethoxy-1H-inden-1-one (8b) (11.0 mg, 0.0409 
mmol, 35%), 2,3-dibromo-4,7-dimethoxy-1H-inden-1-one (17) (2.1 mg, 0.0060 mmol, 5%) and 
4,7-dimethoxy-1H-inden-1-one (18) (2.6 mg, 0.014 mmol, 12%). 
3-Bromo-4,7-dimethoxy-1H-inden-1-one (8b): Bright orange solid. Rf 0.59 (50% EtOAc/hexane). IR ν 
(neat, cm-1): 2918, 1712, 1587, 1496, 1440, 1275, 1028, 772. 1H-NMR (400 MHz, CDCl3): δ 7.03 (d, J = 
9.3 Hz, 1H), 6.90 (d, J = 9.3 Hz, 1H), 6.05 (s, 1H), 3.91 (s, 3H), 3.86 (s, 3H). 13C-NMR (100 MHz, 
CDCl3): δ 192.3, 150.4, 148.2, 142.7, 127.8, 127.7, 122.2, 117.7, 116.8, 56.6, 56.2. HRMS (ESI, 
[M+Na]+): calcd for C11H10O3Br, 268.9808; found, 268.9807. 
2,3-Dibromo-4,7-dimethoxy-1H-inden-1-one (17): Bright red solid. Rf 0.35 (50% EtOAc/hexane). Mp 
162–167 °C. IR ν (neat, cm-1): 2940, 2839, 1712, 1544, 1493, 1275, 1175, 1053, 967, 926, 796.  
1H-NMR (400 MHz, CDCl3): δ 7.03 (d, J = 9.4 Hz, 1H), 6.88 (d, J = 9.4 Hz, 1H), 3.91 (s, 3H), 3.86 (s, 
3H). 13C-NMR (100 MHz, CDCl3): δ 184.4, 151.2, 147.5, 140.3, 127.4, 123.1, 122.3, 117.4, 115.2, 56.7, 
56.4. LRMS (EI) m/z (relative intensity): 350 [M+4]+ (51), 348 [M+2]+ (100), 346 [M]+ (50), 319 (34), 
269 (82), 267 (86), 241 (50), 239 (86), 237 (35), 209 (38), 149 (44), 102 (23). HRMS (EI, [M]+): calcd 
for C11H8O3Br2, 345.8840; found, 345.8830. 
4,7-Dimethoxy-1H-inden-1-one (18): Yellow solid. Rf 0.47 (50% EtOAc/hexane). Mp 72–76 °C. IR ν 
(neat, cm-1): 2941, 2838, 1699, 1592, 1491, 1462, 1439, 1265, 1175, 1089, 1049, 1020, 948, 
825.1H-NMR (400 MHz, CDCl3): δ 7.63 (d, J = 5.9 Hz, 1H), 6.94 (d, J = 9.3 Hz, 1H), 6.80 (d, J = 9.3 Hz, 
1H), 5.74 (d, J = 5.9 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ 196.8, 151.2, 
147.0, 144.5, 132.4, 125.8, 120.8, 116.2, 115.9, 56.4, 56.2. LRMS (EI) m/z (relative intensity): 190 [M]+ 
 
(100), 161 (49), 147 (27), 131 (24), 119 (29), 91 (21). HRMS (EI, [M]+): calcd for C11H10O3, 190.0630; 
found, 190.0634. 
 
1-Oxo-2,3-dihydro-1H-indene-4,7-diyl diacetate (19): To a stirring solution of 16 (165 mg, 0.858 
mmol) in anhydrous CH2Cl2 (2 mL) was added boron tribromide (2.6 mL, 2.6 mmol, 1 M solution in 
CH2Cl2) at −78 °C under argon atmosphere. The resulting mixture was allowed to warm to room 
temperature. After being stirred for 8 h, the reaction mixture was treated with MeOH. The resulting 
mixture was stirred for another 1 h at room temperature and then concentrated in vacuo to yield 
4,7-dihydroxy-2,3-dihydro-1H-inden-1-one as a pale brown solid, which was used for the next reaction 
without further purification. Rf 0.25 (2% MeOH/CHCl3). Mp 168–172 °C. IR ν (neat, cm
-1): 3203, 1653, 
1600, 1476, 1277, 937, 823, 772, 747, 669. 1H-NMR (400 MHz, CD3OD): δ 6.81 (d, J = 8.5 Hz, 1H), 
6.46 (d, J = 8.5 Hz, 1H), 2.87 (t, J = 5.7 Hz, 2H), 2.54 (t, J = 5.7 Hz, 2H). 13C-NMR (100 MHz, 
CD3OD): δ 211.0, 151.2, 148.3, 141.9, 124.6, 124.3, 115.1, 37.0, 23.5. LRMS (EI) m/z (relative 
intensity): 165 [M+1]+ (11), 164 [M]+ (100), 136 (17). HRMS (EI, [M]+): calcd for C9H8O3, 164.0473; 
found, 164.0466. 
 To a stirring solution of the above dihydroxyindanone in anhydrous CH2Cl2 (3 mL) were added 
acetic anhydride (487 μL, 5.15 mmol), triethylamine (1.07 mL, 7.72 mmol) and DMAP (5.2 mg, 0.043 
mmol) under argon atmosphere. After being stirred at room temperature for 11 h, the reaction mixture 
was treated with saturated aqueous NH4Cl. The aqueous layer was extracted with EtOAc twice. The 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in vacuo. The 
residue was purified by silica gel chromatography eluting with 25% EtOAc/hexane to yield the title 
compound (189 mg, 0.761 mmol, 89% for 2 steps) as a white solid. Rf 0.25 (2% MeOH/CHCl3). Mp 
106–110 °C. IR ν (neat, cm-1): 1767, 1715, 1614, 1485, 1369, 1183, 1014, 894, 772. 1H-NMR (400 MHz, 
CDCl3): δ 7.32 (d, J = 8.3 Hz, 1H), 7.00 (d, J = 8.3 Hz, 1H), 2.97 (t, J = 6.1 Hz, 2H), 2.67 (t, J = 6.1 Hz, 
2H), 2.38 (s, 3H), 2.35 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ 202.7, 169.1, 168.4, 148.1, 145.7, 145.0, 
129.9, 128.5, 121.8, 36.3, 22.5, 20.70, 20.66. HRMS (ESI, [M+H]+): calcd for C13H13O5, 249.0757; 
found, 249.0759.  
 
3-Bromo-1-oxo-1H-indene-4,7-diyl diacetate (8c): To a stirring solution of 19 (18.9 mg, 0.0761 mmol) 
in CCl4 (2 mL) were added N-bromosuccinimide (28.5 mg, 0.160 mmol) and 2,2'-azobis(isobutyronitrile) 
(1.3 mg, 0.0079 mmol) under argon atmosphere. The resulting solution was refluxed for 5 h and then 
cooled to room temperature. Triethylamine (30 μL, 0.22 mmol) was added to the mixture and the 
resulting mixture was stirred at room temperature. After being stirred for another 5 h, the mixture was 
treated with 1 M aqueous Na2S2O3. The aqueous layer was extracted with EtOAc twice. The combined 
 
organic layers were washed with brine, dried over MgSO4, and concentrated in vacuo. The residue was 
purified by preparative TLC eluting with 50% EtOAc/hexane to yield the title compound (11.5 mg, 
0.0354 mmol, 47%) as a yellow solid. Rf 0.60 (50% EtOAc/hexane). Mp 133–135 °C. IR ν (neat, cm
-1): 
1770, 1709, 1539, 1473, 1369, 1180, 1090, 1016, 901, 846. 1H-NMR (400 MHz, CDCl3): δ 7.13 (d, J = 
9.3 Hz, 1H), 7.01 (d, J = 9.3 Hz, 1H), 6.21 (s, 1H), 2.372 (s, 3H), 2.367 (s, 3H). 13C-NMR (100 MHz, 
CDCl3): δ 190.0, 169.1, 168.3, 143.4, 142.8, 141.8, 132.5, 131.3, 129.7, 127.1, 122.1, 21.1, 20.7. LRMS 
(EI) m/z (relative intensity): 326 [M+2]+ (2), 324 [M]+ (2), 284 (19), 282 (19), 242 (99), 240 (100), 162 
(38), 161 (74). HRMS (EI, [M]+): calcd for C13H9O5Br, 323.9633; found, 323.9633.  
 
4,7-Dimethoxyspiro[indene-1,2'-naphtho[1,8-de][1,3]dioxin]-3(2H)-one (11a) (Table 1, Entry 2): To 
a stirring solution of 1,8-dihydroxynaphthalene (2) (7.5 mg, 0.047 mmol) and 
3-bromo-4,7-dimethoxy-1H-inden-1-one (8b) (15.2 mg, 0.0565 mmol) in anhydrous CH2Cl2 (0.5 mL) 
was added DABCO (11.5 mg, 0.0941 mmol) at 0 °C under argon atmosphere. After being stirred at room 
temperature for 1.5 h, the reaction mixture was treated with saturated aqueous NH4Cl. The aqueous layer 
was extracted with EtOAc twice. The combined organic layers were washed with brine, dried over 
MgSO4, and concentrated in vacuo. The residue was purified by preparative TLC eluting with 20% 
EtOAc/hexane to yield the title compound (8.2 mg, 0.024 mmol, 50%) as a yellow solid. Rf 0.44 (10% 
EtOAc/toluene). Mp 230–240 °C (decomp). IR ν (neat, cm-1): 3015, 1723, 1608, 1500, 1411, 1379, 1296, 
1271, 1216, 1060, 1028, 757. 1H-NMR (400 MHz, CDCl3): δ 7.54 (d, J = 8.3 Hz, 2H), 7.44 (dd, J = 8.3, 
7.3 Hz, 2H), 7.27 (d, J = 8.9 Hz, 1H), 7.07 (d, J = 8.9 Hz, 1H), 6.97 (d, J = 7.3 Hz, 2H), 3.96 (s, 3H), 
3.90 (s, 3H), 2.91 (s, 2H). 13C-NMR (100 MHz, CDCl3): δ 196.9, 151.1, 151.0, 148.5, 144.8, 134.5, 
127.3, 121.0, 120.5, 114.8, 114.2, 109.8, 103.7, 56.8, 56.3, 49.6 (One signal is missing due to overlap). 
HRMS (ESI, [M+H]+): calcd for C21H17O5, 349.1071; found, 349.1069.  
 
2-Bromo-4,7-dimethoxyspiro[indene-1,2'-naphtho[1,8-de][1,3]dioxin]-3(2H)-one (20) (Table 1, 
Entry 3): By following the procedure described above for 11a, the title compound (10.5 mg, 0.0247 
mmol, 62%, yellow solid) was obtained from 1,8-dihydroxynaphthalene (2) (6.4 mg, 0.040 mmol), 
2,3-dibromo-4,7-dimethoxy-1H-inden-1-one (17) (16.8 mg, 0.0483 mmol) and DABCO (9.8 mg, 0.080 
mmol) through preparative TLC eluting with 20% EtOAc/hexane. Rf 0.30 (10% EtOAc/toluene). Mp 
215–225 °C (decomp). IR ν (neat, cm-1): 3016, 1726, 1608, 1501, 1412, 1378, 1282, 1221, 1060, 819, 
770. 1H-NMR (400 MHz, CDCl3): δ 7.58 (d, J = 8.5 Hz, 1H), 7.57 (d, J = 8.5 Hz, 1H), 7.51 (dd, J = 8.5, 
7.5 Hz, 1H), 7.42 (dd, J = 8.5, 7.5 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 7.12 (d, J = 7.5 Hz, 1H), 7.11 (d, J 
= 9.0 Hz, 1H), 6.92 (d, J = 7.5 Hz, 1H), 4.54 (s, 1H), 3.98 (s, 3H), 3.88 (s, 3H). 13C-NMR (100 MHz, 
 
CDCl3): δ 191.4, 152.2, 151.3, 147.5, 147.3, 134.4, 134.1, 127.6, 127.1, 123.3, 121.6, 121.5, 121.0, 115.4, 
113.6, 110.6, 109.6, 101.6, 56.8, 56.4, 52.7. HRMS (ESI, [M+Na]+): calcd for C21H15O5BrNa, 448.9995; 
found, 448.9991.  
 
3-Oxo-2,3-dihydrospiro[indene-1,2'-naphtho[1,8-de][1,3]dioxine]-4,7-diyl diacetate (11b): By 
following the procedure described above for 11a, the title compound (4.2 mg, 0.010 mmol, 58 %, yellow 
oil) was obtained from 1,8-dihydroxynaphthalene (2) (2.9 mg, 0.018 mmol), 
3-bromo-1-oxo-1H-indene-4,7-diyl diacetate (11b) (7.0 mg, 0.022 mmol) and DABCO (4.0 mg, 0.036 
mmol) through preparative TLC eluting with 13% EtOAc/hexane. Rf 0.37 (10% EtOAc/toluene). IR ν 
(neat, cm-1): 3024, 1773, 1732, 1609, 1490, 1411, 1377, 1274, 1180, 1012, 923, 820, 757. 1H-NMR (400 
MHz, CDCl3): δ 7.57 (d, J = 7.8 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 7.46 (dd, J = 7.8, 7.3 Hz, 2H), 7.33 (d, 
J = 8.5 Hz, 1H), 6.98 (d, J = 7.3 Hz, 2H), 2.91 (s, 2H), 2.40 (s, 3H), 2.14 (s, 3H). 13C-NMR (100 MHz, 
CDCl3): δ 195.1, 169.2, 168.7, 147.9, 145.7, 144.3, 140.7, 134.5, 132.0, 130.1, 127.4, 126.4, 121.4, 113.9, 
109.9, 102.8, 49.2, 20.7 (One signal is missing due to overlap). LRMS (EI) m/z (relative intensity): 404 
[M]+ (29), 362 (14), 321 (24), 320 (100), 303 (31), 149 (17), 85 (10), 71 (13), 57 (13). HRMS (EI, [M]+): 
calcd for C23H16O7, 404.0896; found, 404.0881.  
 
Debromination of 20: To a stirring solution of 20 (10.8 mg, 0.0253 mmol) in acetic acid (0.5 mL) was 
added activated zinc powder (15.0 mg, 0.229 mmol) under argon atmosphere. The resulting suspension 
was stirred at 100 °C for 9 h and then diluted with EtOAc. The resulting mixture was filtered through a 
Celite pad. The filtrate was washed with saturated aqueous NaHCO3 and brine, dried over MgSO4, and 
concentrated in vacuo to yield 11a (8.2 mg, 0.024 mmol, 93%) as a yellow oil, which was pure enough 
for analysis. Spectral data of the compound 11a were in good agreement with that obtained by the double 
oxa-Michael addition of 1,8-dihdroxynaphthalene to 3-bromo-4,7-dimethoxy-1H-inden-1-one (8b), which 
was indicated above.  
 
Palmarumycin C6 (1): To a stirring solution of 11b (4.0 mg, 0.0099 mmol) in MeOH (300 μL) was 
added 6 M aqueous HCl (60 μL) under argon atmosphere. After being refluxed for 3 h, the reaction 
mixture was concentrated in vacuo. The residue was purified by preparative TLC eluting with 25% 
EtOAc/toluene to yield the title compound (3.4 mg, 0.011 mmol, quant.) as a yellow oil. Rf 0.41 (25% 
EtOAc/toluene). IR ν (neat, cm-1): 3236, 2925, 1667, 1602, 1509, 1477, 1413, 1381, 1336, 1303, 1195, 
1108, 1028, 993, 895, 822, 797, 752, 688. 1H-NMR (400 MHz, DMSO-d6): δ 9.83 (br-s, 1H), 9.56 (br-s, 
1H), 7.61 (d, J = 8.3 Hz, 2H), 7.50 (dd, J = 8.3, 7.6 Hz, 2H), 7.14 (d, J = 8.6 Hz, 1H), 7.00 (d, J = 7.6 Hz, 
2H), 6.96 (d, J = 8.6 Hz, 1H), 2.76 (s, 2H). 13C-NMR (100 MHz, DMSO-d6): δ 196.8, 148.2, 147.4, 
 
134.0, 131.7, 127.5, 125.7, 123.0, 120.6, 120.4, 113.5, 109.5, 103.4, 49.0 (One signal is missing due to 
overlap). HRMS (ESI, [M+H]+): calcd for C19H13O5, 321.0757; found, 321.0751.  
Spectral data of synthesized 1 were in good agreement with that reported by Krohn et al.2  
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